Because passions should rule one’s life. Not diabetes!

Diabeloop partners with patients: Since its creation, Diabeloop has been involving people living with Type 1 or Type 2 diabetes and their relatives from the very first phases of development of its innovations, alongside engineers and doctors.

The creation of intuitive interfaces for the personalized solutions developed by Diabeloop are inspired by the requests of patients and their personal experiences, so that they can spend less time on their diabetes, and more on their passions!

The international launch of an independent young company

In November 2018, Diabeloop’s first medical device, DBLG1, was CE marked. We are working on commercializing, in Europe (France and Germany at first) and later in North America.

To support our international ambition and our Research and Development roadmap, we completed a Series B round of funding, setting a European fundraising record for therapeutic artificial intelligence.

Discover the company

Our latest news

04/19/2022

Deep dive into the creative world of Noëllie, Artistic Director at Diabeloop

Her main mission? Being all ears to anyone who wants...

03/29/2022

Lancet Digital Health publication: Diabeloop’s hybrid closed-loop system assessed in children with Type 1 diabetes

Significant improvements in time-in-range and reduction of hypoglycemia

02/21/2022

Margaux, Key Account Manager, has progressed in her career in line with Diabeloop’s growth

From Business Analyst to Key Account Manager, they discuss their...

Reduce the heavy burden for people with diabetes

Diabeloop developed a self-learning algorithm that embeds therapeutic artificial intelligence, to automate Type 1 diabetes treatment. It is intended to relieve people affected by this chronic condition from having to make constant therapeutic decisions every day and night, and to allow them to live life without interruption.

Our products